Use of Nimotuzumab and Radiotherapy in the Treatment of Pediatric Patients With Diffuse Intrinsic Brainstem Glioma.
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2016
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Acronyms POLARIS
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 02 Jun 2015 Status changed from recruiting to completed, as reported at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 19 Jan 2012 Additional lead trial investigators identified as reported by ClinicalTrials.gov.